These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37655327)

  • 41. Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the l-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade.
    Hu Y; Lin L; Chen J; Hao K; Zhang S; Guo X; Guo Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41127-41137. PubMed ID: 32808767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen-Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal-Immunotherapy.
    Pan J; Wang Y; Zhang C; Wang X; Wang H; Wang J; Yuan Y; Wang X; Zhang X; Yu C; Sun SK; Yan XP
    Adv Mater; 2018 Feb; 30(8):. PubMed ID: 29318677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy.
    Gao ZL; Xu W; Zheng SJ; Duan QJ; Liu R; Du JZ
    Nano Lett; 2023 Mar; 23(5):1904-1913. PubMed ID: 36801829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy.
    Xie X; Feng Y; Zhang H; Su Q; Song T; Yang G; Li N; Wei X; Li T; Qin X; Li S; Wu C; Zhang X; Wang G; Liu Y; Yang H
    Bioact Mater; 2022 Oct; 16():107-119. PubMed ID: 35386322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy.
    Xu J; Wang H; Xu L; Chao Y; Wang C; Han X; Dong Z; Chang H; Peng R; Cheng Y; Liu Z
    Biomaterials; 2019 Jul; 207():1-9. PubMed ID: 30947117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A MnAl double adjuvant nanovaccine to induce strong humoral and cellular immune responses.
    Qiao N; Wang H; Xu Y; Chang Y; Xie M; Bai S; He C; Qin M; Zhong X; Jiang M; Guo Z; Du G; Zhang Z; Zhang Y; Sun X
    J Control Release; 2023 Jun; 358():190-203. PubMed ID: 37116543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanovaccine-Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy.
    Qin L; Zhang H; Zhou Y; Umeshappa CS; Gao H
    Small; 2021 Jul; 17(28):e2006000. PubMed ID: 33768693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy.
    Chen H; Cheng H; Liang X; Cai S; Liu G
    Front Immunol; 2022; 13():934259. PubMed ID: 35812415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma.
    Chu Y; Qian L; Ke Y; Feng X; Chen X; Liu F; Yu L; Zhang L; Tao Y; Xu R; Wei J; Liu B; Liu Q
    J Nanobiotechnology; 2022 Apr; 20(1):190. PubMed ID: 35418151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancement of Immune Response of Bioconjugate Nanovaccine by Loading of CpG through Click Chemistry.
    Mo M; Li X; Li C; Wang K; Li S; Guo Y; Sun P; Wu J; Lu Y; Pan C; Wang H
    J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-Adjuvanted Molecular Activator (SeaMac) Nanovaccines Promote Cancer Immunotherapy.
    Luo Z; He T; Liu P; Yi Z; Zhu S; Liang X; Kang E; Gong C; Liu X
    Adv Healthc Mater; 2021 Apr; 10(7):e2002080. PubMed ID: 33336537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new polysaccharide platform constructs self-adjuvant nanovaccines to enhance immune responses.
    Chen S; Yang L; Ou X; Li JY; Zi CT; Wang H; Hu JM; Liu Y
    J Nanobiotechnology; 2022 Jul; 20(1):320. PubMed ID: 35836236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Personalized Nanovaccine Coated with Calcinetin-Expressed Cancer Cell Membrane Antigen for Cancer Immunotherapy.
    Xiong X; Zhao J; Pan J; Liu C; Guo X; Zhou S
    Nano Lett; 2021 Oct; 21(19):8418-8425. PubMed ID: 34546061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
    Cruz LJ; Tacken PJ; Bonetto F; Buschow SI; Croes HJ; Wijers M; de Vries IJ; Figdor CG
    Mol Pharm; 2011 Apr; 8(2):520-31. PubMed ID: 21381651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-signaling pathway activation by pH responsive manganese particles for enhanced vaccination.
    Lv X; Huang J; Min J; Wang H; Xu Y; Zhang Z; Zhou X; Wang J; Liu Z; Zhao H
    J Control Release; 2023 May; 357():109-119. PubMed ID: 36738971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dendritic cell-based nanovaccines for cancer immunotherapy.
    Paulis LE; Mandal S; Kreutz M; Figdor CG
    Curr Opin Immunol; 2013 Jun; 25(3):389-95. PubMed ID: 23571027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A "trained immunity" inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice.
    Li D; Li W; Zheng P; Yang Y; Liu Q; Hu Y; He J; Long Q; Ma Y
    J Nanobiotechnology; 2023 Mar; 21(1):74. PubMed ID: 36864424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma.
    Dai H; Huang Y; Guo J; Li L; Ke Y; Cen L; Meng F; Chen X; Liu B; Qian X
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52634-52642. PubMed ID: 36383430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.